Cargando…
Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation
Favipiravir and remdesivir have been included in the COVID-19 treatment guidelines panel of several countries. The main objective of the current work is to develop the first validated green spectrophotometric methods for the determination of favipiravir and remdesivir in spiked human plasma. The UV...
Autores principales: | Batubara, Afnan S., Abdelazim, Ahmed H., Almrasy, Ahmed A., Gamal, Mohammed, Ramzy, Sherif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273576/ https://www.ncbi.nlm.nih.gov/pubmed/37328879 http://dx.doi.org/10.1186/s13065-023-00967-6 |
Ejemplares similares
-
Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
por: Imam, Mohamed S., et al.
Publicado: (2023) -
Green fitted second derivative synchronous spectrofluorometric method for simultaneous determination of remdesivir and apixaban at Nano gram scale in the spiked human plasma
por: Batubara, Afnan S., et al.
Publicado: (2023) -
Green-adapted spectrophotometric determination of fostemsavir based on selective bromophenol blue extraction; reduction of hazardous consumption using computational calculations
por: Batubara, Afnan S., et al.
Publicado: (2023) -
Simultaneous green TLC determination of nirmatrelvir and ritonavir in the pharmaceutical dosage form and spiked human plasma
por: Imam, Mohamed S., et al.
Publicado: (2023) -
Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma
por: Imam, Mohamed S., et al.
Publicado: (2023)